Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Concenter BioPharma

Concenter BioPharma
2014 FOUNDED
PRIVATE STATUS
1-10 EMPLOYEES
Angel LATEST DEAL TYPE (Announced)
$5M LATEST DEAL AMOUNT
Description

Developer of non-steroidal chemical complexes designed to cure inflammatory disorders of multiple indications. The company's non-steroidal chemical complexes offer medicinal products like drugs having anti-inflammatory, iron chelating and antibiotic agents which can be used to treat skin disorders, type 2 diabetes and pulmonary diseases, enabling patients to recover inflammatory disorders.

Ownership Status
Privately Held (backing)
Financing Status
Angel-Backed
Primary Industry
Pharmaceuticals
Other Industries
Drug Discovery
Biotechnology
Primary Office
  • 18 Yahalom Street
  • Tel Mond 4061818
  • Israel

+972 000-000-0000
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Concenter BioPharma’s full profile, request a free trial.

Concenter BioPharma Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Angel (individual) 13-Jan-2020 $5M 000 Announced Startup
2. Angel (individual) 25-May-2016 000 000 Completed Startup
1. Capitalization Completed Startup
To view this company’s complete deal history including valuation and funding, request access »

Concenter BioPharma Executive Team (2)

Name Title Board
Seat
Contact
Info
Dror Chevion Co-Founder & Chief Executive Officer
Mordechai Chevion Ph.D Chief Scientific Officer & Co-Founder